A5079626281- Cardiac Structural Anomalies and Repair
- Transplantation: Methods and Outcomes
- COVID-19 Clinical Research Studies
- Cardiac Valve Diseases and Treatments
- Acute Myocardial Infarction Research
- Acute Myeloid Leukemia Research
- Cardiovascular Issues in Pregnancy
- Sexual Differentiation and Disorders
- Renal cell carcinoma treatment
- Renal Transplantation Outcomes and Treatments
- COVID-19 and healthcare impacts
- MRI in cancer diagnosis
- Multiple Myeloma Research and Treatments
- Viral Infections and Immunology Research
- Infective Endocarditis Diagnosis and Management
- Cardiac Imaging and Diagnostics
- Cardiac Arrhythmias and Treatments
- Renal and Vascular Pathologies
- Diverse Scientific and Economic Studies
- Chemokine receptors and signaling
- Medical Imaging Techniques and Applications
- Cardiac Arrest and Resuscitation
New York City Health and Hospitals Corporation
2025
Mount Sinai Hospital
2025
Cedars-Sinai Medical Center
2020-2021
Cedars-Sinai Smidt Heart Institute
2020
Stony Brook University
2015
Consideration of thrombolysis as first-line reperfusion therapy in patients with COVID-19 and STEMI is recommended by ACC/SCAI guidelines. We describe a patient COVID-19, who presented ST-elevation myocardial infarction was treated anticoagulation. He later found to have significant persistent thrombus burden requiring thrombectomy stent placement. Invasive hemodynamics on multiple high-dose pressers revealed high cardiac output state low systemic vascular resistance, consistent distributive...
Abstract Donor‐specific antibodies (DSAs) in patients prior to heart transplantation are associated with increased risk of rejection and can lead longer waitlist times, but it is not known whether low/moderate‐level DSA at transplant have acceptable post‐transplant outcomes. We performed a single‐center, retrospective review examine outcomes crossing pre‐existing DSA. assessed 864 awaiting between 2010 2018, identified 67 compared them who were sensitized without the time transplantation, as...
Background: Kidney and renal pelvic cancer was the sixth most common in men 10th women United States 2018. Renal cell carcinoma (RCC), accounts for 86% of malignancies kidney. RCC patients are often asymptomatic; up to 25-30% have metastases at diagnosis. Few present with triad gross hematuria, flank pain, abdominal mass. In patients, 36% had 2 symptoms triad, 60% hematuria as 1 symptom. Point-of-care ultrasound (POCUS) offers a way identify clinically meaningful anatomic abnormalities. This...